Results 241 to 250 of about 357,928 (304)

Abnormal functional connectivity patterns in temporal lobe epilepsy—An international ENIGMA‐epilepsy study

Epilepsia Open, EarlyView.
Abstract Objectives Temporal lobe epilepsy (TLE) impacts multiple brain networks. Aberrant functional connectivity has been demonstrated in resting‐state networks (RSNs) that mediate higher brain functions in TLE. This study aimed to identify the reproducible patterns of altered functional connectivity in TLE in a large, international cohort through ...
Victoria Ives‐Deliperi, Jonathan Ipser, James T. Butler, Heath Pardoe, Hamid Soltanian‐Zadeh, Christian Rummel, Roland Wiest, Simon S. Keller, Barbara A. K. Kreilkamp, Anna Elisabetta Vaudano, Alice Ballerini, Stefano Meletti, Gerard Hall, Peter Taylor, Luis Concha, Alfonso Fajardo‐Valdez, Raphael Fernandes Casseb, Fernando Cendes, Clarissa L. Yasuda, Louis Lemieux, John S. Duncan, Esmaeil Davoodi‐Bodj, Orrin Devinsky, Sophia I. Thomopoulos, Dan J. Stein, Paul M. Thompson, Sanjay M. Sisodiya, Taha Gholipour, Carrie R. McDonald   +28 more
wiley   +1 more source

Neuroanatomical correlates of neuropsychological dysfunction in pediatric pharmacoresistant epilepsy due to focal cortical dysplasia type II

Epilepsia Open, EarlyView.
Abstract Objective Children and adolescents with pharmacoresistant epilepsy (PRE) show marked individual cognitive and emotional variability not fully accounted for by demographic or clinical variables. This exploratory pilot study characterizes neuroanatomical abnormalities and their relationships with neuropsychological functioning in a pediatric ...
Ana Arenivas, Spencer Morris, Brittany Lapin, Yadi Li, Lisa Ferguson, Stephen E. Jones, Ingmar Blümcke, Imad Najm, Robyn M. Busch, Zhong Irene Wang   +9 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Laboratory biomarkers of Multiple Sclerosis (MS)

Clinical Biochemistry, 2022
Multiple Sclerosis (MS) is a neurological disease that affects the central nervous system (CNS). The diagnosis of the disease is quite challenging due to its variation among patients. As a result, the need to enhance diagnostic procedures, evaluate objective prognostic markers and promote effective monitoring of patients' responses to treatment has ...
Borros, Arneth, Jörg, Kraus
openaire   +2 more sources

Fulminant multiple sclerosis (MS)

Neurological Sciences, 2011
Fulminant multiple sclerosis (MS) is the most malignant form of MS which usually leads to death in few weeks. Although it can be accompanied by optic neuritis (ON), but long interval between ON and the grave onset has not been reported. Fulminant MS usually occurs as the first onset and previous ON is not common.
Mohammad, Rohani, Shadi, Ghourchian
openaire   +2 more sources

Patient with Multiple Sclerosis (MS)

2020
Pain is a prevalent and debilitating symptom of multiple sclerosis (MS) often requiring inpatient management. This chapter demonstrates medical management of pain in multiple sclerosis patients. Beginning with epidemiology of pain requiring inpatient management, the prevalence and pathophysiology of pain will be discussed.
Chandni B. Patel, Ankur A. Patel, Navdeep S. Jassal   +2 more
openaire   +1 more source

Dopamine, T cells and multiple sclerosis (MS)

Journal of Neural Transmission, 2017
Dopamine is a key neurotransmitter that induces critical effects in the nervous system and in many peripheral organs, via 5 dopamine receptors (DRs): D1R-D5R. Dopamine also induces many direct and very potent effects on many DR-expressing immune cells, primarily T cells and dendritic cells.
Levite, Mia, MARINO, FRANCA, COSENTINO, MARCO   +2 more
openaire   +2 more sources

Multiple sclerosis specific antigens in MS brains

Acta Neurologica Scandinavica, 2009
Antigens in MS and non-MS brains were investigated by means of crossed immunoelectrophoresis. Two MS specific antigens were found: a measles antigen which was present in microsomes and cytosole, and an unidentified antigen present only in cytosole.
S C, Rastogi, J, Clausen, T, Fog
openaire   +2 more sources

Coffee and multiple sclerosis (MS)

Multiple Sclerosis (MS) is a long-term autoimmune disorder affecting the central nervous system, marked by inflammation, demyelination, and neurodegeneration. While the exact cause of MS remains unknown, recent research indicates that environmental factors, particularly diet, may influence the disease's risk and progression.
Youssef K. Ghallab, Omnia S. Elassal, Ruth G. Mina   +2 more
openaire   +2 more sources

Animal Models of Multiple Sclerosis (MS)

2017
Multiple sclerosis is the chronic autoimmune disorder of the sensory system coordinated against its own particular myelin antigens. It is the basic incapacitating neurological illness influencing generally youth and grown-ups between the age of 20 and 40 years. Myelin is a protein that makes up the myelin sheath around the nerve fibers (axons).
Shubhangi Gupta, Sanpreet Kour, Rahul Deshmukh   +2 more
openaire   +1 more source